Chronic total parenteral nutrition (TPN) markedly augments net hepatic glucose uptake (NHGU). This adaptive increase is impaired by an infection despite accompanying hyperinsulinemia. In the non-adapted state NHGU is dependent upon the prevailing glucose levels. Our aims were to determine if the adaptation to TPN alters the glucose dependency of NHGU, if infection impairs this dependency and if insulin modulates the glucose dependency of NHGU during infection. Chronically catheterized dogs received TPN for 5 days. On day 3 of TPN dogs received either a bacterial fibrin clot to induce a non-lethal infection (INF, n=9) or a sterile fibrin clot (SHAM, n=6).
Introduction
The liver is an important site of glucose uptake during the fed state (23)removing about 1/3 of an oral glucose load (17) . The liver's capacity to remove glucose is further enhanced during continuous nutritional support (3) . The magnitude of liver glucose uptake (NHGU) is determined primarily by three variables: liver blood flow, inflowing glucose concentration to the liver and net fractional hepatic glucose extraction (23) .
Liver blood flow increases only modestly (↑20%) in response to mixed meal feeding (18) . In contrast glucose concentration can change as much as 2-fold and the net fractional hepatic glucose extraction can vary from zero to 5% during a meal to as high as 15% during nutritional support. Thus, glucose concentration and net fractional hepatic glucose extraction are the regulated physiologic variables that primarily determine the magnitude of liver glucose uptake.
The glucose dependency of liver glucose uptake is influenced by the route of glucose delivery and the prevailing insulin levels. In the overnight fasted state a two-fold increase in glucose concentration in the presence of basal insulin level suppresses liver glucose production and switches the liver to be a modest consumer of glucose (~0.5 mg/kg/min). This is accompanied by a modest rise (1%) in net fractional hepatic glucose extraction (20) . When combined with a physiologic rise in insulin (4 x basal) NHGU increases to ~2 mg/kg/min. NHGU is further enhanced up to ~4 mg/kg/min if the glucose is administered into the portal vein, which activates the portal signal (23) .
It is unclear whether the liver will respond to the normal physiologic regulators of liver glucose uptake in the TPN-adapted state. With this adaptation liver glucose uptake 3 Final accepted version E- 00286-2003.R2 (~4 mg/kg/min) and fractional extraction (15%) are already high in the absence of significant hyperglycemia (120 mg/dl) or hyperinsulinemia (1.2 x basal). We previously observed that the adapted liver is poorly responsive to increases in insulin (6) . In contrast to the non-adapted setting where a four fold increase in insulin increases liver glucose uptake more than 4-fold, in the TPN-adapted setting a four fold rise in insulin only enhanced liver glucose uptake by 25%. Whether, this augmentation in hepatic glucose uptake and fractional extraction seen during TPN would alter the dependency of liver glucose uptake on glucose concentration is unknown.
During hypermetabolic infection liver glucose uptake is markedly curtailed despite accompanying hyperinsulinemia. This impairment is seen both in response to an acute glucose load into a peripheral vein (15) as well as in the chronic TPN-adapted setting (14) . The mechanism for this impairment is unknown, however, accompanying increases in glucagon, other stress hormones and cytokines and hepatic insulin resistance likely contribute. Despite this impairment NHGU remains greater than that which would be seen in the non-adapted setting. It is unclear if the infection-induced impairment in NHGU would alter the dependency of liver glucose uptake on the prevailing glucose levels. Moreover it is unclear if the accompanying hyperinsulinemia, which limits the fall in NHGU (5) , would help to sustain the glucose dependency of NHGU. If NHGU is more dependent upon the prevailing glucose levels than on the compensatory hyperinsulinemia, then despite the underlying impairment in liver glucose uptake, treatment options (e.g. insulin infusion) that lower arterial glucose levels may not correct the already low liver glucose uptake. 4 Final accepted version E- 00286-2003.R2 Thus the aims of the study were to determine 1) if the glucose dependency of liver glucose uptake is augmented by TPN, 2) if infection impairs the glucose dependency of liver glucose uptake, and 3) if insulin can modulate the glucose dependency of liver glucose uptake during infection. To address these aims net hepatic glucose uptake was assessed in chronically catheterized normal and infected dogs receiving TPN.
Methods
Animal preparation. Fifteen female non-pregnant mongrel dogs were fed standard Kal-Kan meat (Vernon, CA) and Purina Lab Canine Diet #5006 (Purina Mills, St. Louis, MO) once daily and had free access to water. The composition of the diet based on dry weight was 52% carbohydrate, 31% protein, 11% fat, and 6% fiber. Dogs were housed in a facility that met American Association for the Accreditation of Laboratory Animal Care
International Guidelines. The protocols were approved by the Vanderbilt University Medical Center Animal Care Committee. The health of the animals was determined before surgery and before TPN administration as having: a good appetite (i.e., consumed at least ¾ of the daily ration), normal stools, hematocrit >35%, and leukocyte count < 18,000 mm -3 .
Experimental preparation. A laparotomy was performed using sterile techniques with general anesthesia (15 mg/kg thiopental sodium iv for induction and 1.0% isoflurane as an inhalant during surgery) on healthy dogs. During the laparotomy, Silastic catheters were positioned about the portal vein, hepatic artery, and right external iliac artery. After an incision was made in the left inguinal region, a sampling catheter (0.04 in. ID) was placed in the left common iliac vein, and the tip was positioned distal to the anastomosis with the IVC. After an incision in the right inguinal region, a catheter was advanced from the right external iliac artery to the abdominal aorta.
All catheters were filled with 0.9% NaCl (saline) containing heparin (200 U/ml).
The free ends of the catheters and flow probes were exteriorized and placed in subcutaneous pockets. The dogs received penicillin G (500,000 U iv) in 1 liter of saline to minimize the possibility of infection. Flunixamine (0.1 mg/kg; Fort Dodge Laboratory, Fort Dodge, IA) was injected intramuscularly immediately after wound closure for acute pain relief. Dogs also received penicillin G (600,000 U im) for 3 days after surgery.
Nutritional support. After allowing at least 14 days for recovery from surgery, each dog's IVC catheters were exteriorized under local anesthesia (2% Lidocaine;
Abbott, North Chicago, IL). TPN was infused into one of these catheters with an ambulatory infusion pump (Dakmed, Buffalo, NY). Dogs wore a jacket (Alice King
Chatham, Los Angeles, CA) with two large pockets for the TPN bag and pump.
The dogs received TPN as the sole exogenous caloric source for 5 days. The TPN was designed to be isocaloric, based on predicted resting energy expenditure (25 under sterile conditions. Bacteria were mixed with the filtrate, and thrombin (1,000 U;
Gentrac, Middleton, WI) was added to initiate clot formation.
On the third day of the 5-day TPN infusion, a second laparotomy was performed under anesthesia. An abdominal midline incision was made at a point caudal to that made during the first surgery; the infected clot was then implanted in the peritoneal cavity.
Animals received 500 ml of saline during the laparotomy and 1000 ml the next day.
During the course of the infection, animals were monitored closely. The same procedure was followed for Sham (n=6) dogs, except they received a sterile clot and 500 ml of saline on the subsequent day. Infected animals (n=9) were typically normotensive, hyperthermic, and tachycardic, with a characteristic increase in hepatic arterial blood flow (HABF) (14) . In all animals a pancreatic clamp was performed in which SRIF was infused (0.8 µg/kg/min) to suppress endogenous insulin and glucagon secretion. In one group of infected animals insulin (porcine regular Iletin II; Eli Lilly, Indianapolis, IN) and glucagon (Eli Lilly) were replaced intraportally by infusion into the splenic and jejunal veins at rates of 1,000 µU/kg/min and 2.5 ng/kg/min, respectively, to simulate the levels seen during infection (INF-Hi; n=5). The other infected group received insulin at a rate designed to match the concentration seen in the SHAM group (400 µU/kg/min; INF-Lo; n=4) and received glucagon (2.5 ng/kg/min) to simulate the levels seen during infection.
For the SHAM group (Sham; n=6) insulin (400 µU/kg/min), and glucagon (0.1 ng/kg/min) were infused to match the levels observed previously in sham animals (14) .
All solutions were infused with calibrated syringe pumps (Harvard Apparatus, Holliston, MA). The glucose infusion rate (GIR) in the TPN was adjusted regularly to obtain the desired glucose levels, whereas the other components of the TPN were infused at the constant rate for the duration of the experiment. (24) and charged intermediates were removed (13) . The remaining plasma was stored at -70º C for later analyses.
Analysis. Immunoreactive insulin and glucagon were assayed using a double antibody technique [(19)intra-assay coefficient of variation (CV) 11% and 10%, respectively], and cortisol was assayed with Diagnostic Products (Los Angeles, CA) RIA Kit (CV 12%)(7) HPLC methods were used to assess plasma epinephrine and norepinephrine (CV 15% and 12% respectively) (8) .
[blood flow × (1-hematocrit)]. Net hepatic substrate uptake was the difference between Load In and Load Out. Net hepatic substrate fractional extraction was calculated as the ratio of net hepatic substrate uptake and Load In.
These equations were used to calculate net hepatic glucose, Enzyme analysis. Hepatic glycogen content was determined using the enzymatic method of Chan and Exton (2) . Tissue glucokinase (GK) and glucose-6-phosphatase (G6Pase) activities were analyzed on the quadrate lobe with the methods described by
Barzilai and Rossetti(1). Total GK activity was calculated as the difference between activities at 100 and 0.5 mM glucose. G6Pase was measured at 10 mM glucose-6-phosphate (G6P). Protein content was assessed with the Biuret Method. Glycogen synthase (GS) activity was assessed in the presence (total) and absence (active) of 6.6 mM Glucose 6 phosphate (G6P) (26) . The ratio of these two activities (-G6P/+G6P) is an estimate of the activation state of the enzyme. Glycogen phosphorylase activity was assessed in the presence of 7.5 mM AMP (total) or 0.75 mM caffeine (active) (9) . Tissue G6P, and fructose-2,6-bisphosphate (F2,6P 2 ) were analyzed using fluorometric enzymatic methods (16;28).
Statistics. All mean and SE values reported for the basal period are the means of the 40-min period using three time points. For the experimental periods, the mean of the last 30 min of each glucose step was used. Statistical comparisons were made with twoway ANOVA vs. change from basal for infected groups followed by an F test (SYSTAT, Evanston, IL), and one-way ANOVA when comparing Sham and infected groups. P < 0.05 was regarded as significant.
Results
Hemodynamic Parameters. Body temperature, heart rate, mean arterial pressure, and blood flow (hepatic artery, portal vein and iliac artery) were measured in SHAM,
INF-Hi and INF-Lo groups (Table 1) . Infected groups showed characteristic increases in body temperature, heart rate and hepatic arterial blood flow. Portal vein and iliac arterial blood flow was not different between the three groups during the basal period. Blood flow did not change over time in any group during experimental period (data not shown). Hepatic glucose kinetics. In each group hepatic glucose load (HGL) increased as glucose concentration was increased (Fig. 2) . At each glucose step HGL was lower INF-Groups, Fig 3) . Net fractional hepatic glucose extraction (NFHGE) was markedly decreased by infection (p<0.05). While NFHGE increased progressively as arterial blood glucose concentration was increased in all groups; it appeared to saturate at high arterial glucose concentrations in the infected group (Fig 3) . NHLR did not increase as arterial blood glucose concentration and NHGU increased in each group (Fig. 5) . Consequently, the fraction of NHGU converted to lactate did not increase as arterial glucose levels-rose in all three groups.
During the basal period the arterial alanine concentration was decreased with infection (p<0.05, SHAM group vs. INF-groups) ( Arterial glycerol concentration and hepatic glycerol uptake were not altered by infection ( Table 2) . Lowering of insulin concentration in INF-Lo did not alter arterial glycerol concentration or net hepatic glycerol uptake. There were no significant changes in glycerol metabolism in the experimental period for all three groups.
Arterial plasma NEFA concentrations in the basal period were similar in all groups and were unaltered during hyperglycemia. However, net hepatic NEFA uptake (Fig. 6) , shown as the area between the NHGU and NHRL + CO 2 . Moreover the net rate of glucose storage was substantially greater (p<0.05) in the SHAM group than in both infected groups at all elevated glucose loads.
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The glucose was primarily stored as glycogen, as evidenced by substantial tracer incorporation into liver glycogen (Table 3) .
Liver glycogen content was significantly higher in the SHAM group than in the infected groups. The glucose-6-phosphate concentration, glucose-6-phosphatase and glucokinase activities in liver in SHAM, INF-Hi and INF-Lo were not significantly different (Table 3) . However the glycogen synthase activity and activity ratio as well as fructose 2,6 bis-phosphate were decreased in the infected groups. Glycogen phosphorylase activity was increased (p<0.05) in the infected groups. (Table 4) was not altered by infection and did not increase as glucose levels increased. TPN enhances glucose-dependent liver glucose uptake. As we have seen previously liver glucose uptake was markedly increased by TPN in the presence of mild elevations of glucose and insulin (3) . In the present study as glucose levels were increased liver glucose uptake increased in proportion to the rise in glucose levels. A rise in the arterial glucose levels from 120 to 250 mg/dl increased NHGU from 4.5 to 11.5 mg/kg/min. This glucose-dependent response in the TPN adapted setting is in marked contrast to the non-adapted setting where mild hyperglycemia (120mg/dl) and hyperinsulinemia (15 µU/ml) would not initiate NHGU (20) . Moreover even in the presence of elevated insulin levels a doubling of glucose load (Figure 4 ; shaded area) in the presence of hyperinsulinemia (~30 µU/ml) would only increase NHGU from 0.5 to 4 mg/kg/min (21) .
Non-hepatic, hindlimb and intestine glucose metabolism. (Fig
Infection impaired glucose-dependent NHGU. As we have seen previously infection impairs liver glucose uptake despite accompanying hyperinsulinemia and mild hyperglycemia (14) . NHGU was decreased by ~50% at each glucose concentration in the infected groups. However not only was NHGU decreased but the dependency of NHGU on arterial glucose levels was decreased by 35%. The extent of the defect in the responsiveness of the liver to take up glucose during infection is even more apparent if one examines the relationship between hepatic glucose load and NHGU (Fig 4) . The slope of this relationship was decreased by more than 50%. Interestingly, in contrast to the normal animal where both net fractional hepatic glucose extraction and NHGU rose as glucose was increased, net fractional hepatic glucose extraction tended to saturate at high glucose levels in the infected animal thus limiting the rise in NHGU (Fig 3) .
Hyperinsulinemia accompanying infection did little to improve glucosedependent liver glucose uptake. In our previous study (5) , the compensatory rise in insulin helped to limit the fall in NHGU (∆1.4±0.5 mg/kg/min) during infection in the presence of mild hyperglycemia (120 mg/dl). In this study, NHGU tended to be lower (∆0.8 mg/kg/min) when insulin was suppressed, however this was not significant. In part this may be due to the already low NHGU in INF-HI, which could not be suppressed further by lowering insulin levels. The slope of the relationship between NHGU and either glucose levels or glucose load was identical in the two infected groups. This suggests that additional insulin does little to correct the infection induced impairment in glucose-dependent NHGU. There are however two caveats. First, in INF-Lo at the highest glucose levels insulin levels rose indicating that somatostatin was not completely effective in suppressing endogenous insulin secretion. Second, the limited number of Impairment in glycogen synthesis is the mechanism for the infection induced decrease in NHGU. While the major metabolic fate of glucose within the liver in the TPN adapted state is diversion to glycolysis and subsequent release as lactate, acute increases in arterial glucose levels did not increase net hepatic lactate release. The primary metabolic fate was glycogen. This was confirmed by gradual rise net hepatic glucose storage ( Fig. 7 ) and significant incorporation of 3 H glucose into glycogen. A likely explanation for this is a glucose dependent increase in glycogen synthase activity (4).
Infection decreased both glucose-dependent NHGU and glycogen synthesis (Fig. 7) .
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This impairment was confirmed by both a decrease in net glycogen storage and 3 H glucose incorporation into glycogen. The later will tend to overestimate the impairment in total glycogen synthesis in the infected groups to the extent indirect glycogen synthesis is higher in the infected group. However net glycogen storage was also suppressed and it takes into account differences in gluconeogenic precursor uptake. Analysis of liver biopsies obtained at the end of the study indicated that the impairment in glycogen synthesis was not due to differences in either glucokinase or glucose 6 phosphatase.
However both total glycogen synthase and its activity ratio were markedly decreased and there was a corresponding rise in glycogen phosphorylase. Thus the ratio of the active glycogen synthase and phosphorylase fell by over 90%. Moreover the fall in hepatic glycolysis seen during infection is likely explained by an 80% reduction in fructose 2,6
bis-phosphate levels during infection. The mechanism for the enzymatic alterations is likely due to hepatic insulin resistance and the accompanying hyperglucagonemia of infection.
The compensatory hyperinsulinemia serves to overcome the infection induced impairment in liver glucose uptake by diverting the exogenous glucose to peripheral (ie.
non-hepatic) tissues. As we have seen previously at basal glucose levels (120 mg/dl), non-hepatic glucose uptake was enhanced with infection (INS-HI) relative to the SHAM group. (5). Non-hepatic glucose uptake was decreased in INF-Lo to the rate seen in the SHAM group. Interestingly glucose-dependent non-hepatic glucose uptake (i.e. slope of the relationship between glucose levels and Non-HGU) was impaired by infection (p<0.05). The additional insulin seen during infection raised non hepatic glucose uptake, however, it did not augment the glucose dependency of non hepatic glucose uptake. The failure of insulin to increase glucose dependent glucose uptake is consistent with insulin resistance in the periphery during infection (5;10). As we have seen previously (6) at low insulin levels detecting a decrease in insulin mediated peripheral glucose uptake is difficult, because infection enhances insulin-independent glucose uptake. It is only when insulin levels are increased that the insulin resistance is apparent.
As a consequence of the pronounced effects of infection on hepatic metabolism and its resistance to the effects of insulin, the compensatory hyperinsulinemia seen during 
Significance:
A recent clinical trial indicates that aggressive normalization of glucose levels in hospitalized ICU patients decreases morbidity and mortality (27) . 
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